SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-09-27 11:28
Tx date 2022-09-26
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.)
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+175,000 vol
475,000
Filed 2021-10-14 13:27
Tx date 2021-10-13
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.)
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,000
-5,000 vol
$0.20 each
645,000
Filed 2021-07-15 15:27
Tx date 2021-06-24
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.)
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
300,000
Filed 2021-07-15 13:47
Tx date 2021-06-24
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.)
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-07-15 13:47
Tx date 2021-06-24
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.)
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
300,000
Filed 2021-07-15 13:37
Tx date 2021-06-24
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.)
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
650,000
Filed 2021-07-15 13:37
Tx date 2021-06-24
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.)
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
275,000
Filed 2021-07-15 13:31
Tx date 2021-06-23
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.)
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-07-15 13:31
Tx date 2021-06-23
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.)
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2021-07-15 13:23
Tx date 2021-06-25
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.)
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2021-07-15 13:23
Tx date 2021-06-25
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.)
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-06-24 15:29
Tx date 2021-06-14
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.)
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2021-06-24 15:26
Tx date 2021-06-14
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.)
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2021-06-24 13:04
Tx date 2021-06-14
$MRVL
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.)
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-06-24 15:29
Tx date 2021-06-14
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.)
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
275,000
Filed 2021-06-24 15:26
Tx date 2021-06-14
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.)
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2021-06-24 13:04
Tx date 2021-06-14
$AVC
Marvel Biosciences Corp. (Formerly Alphanco Venture Corp.)
Groot, Jacqueline
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
650,000